U.S. Markets closed

Enochian Biosciences, Inc. (ENOB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.98-0.08 (-1.13%)
At close: 4:00PM EDT
6.85 -0.13 (-1.86%)
After hours: 05:12PM EDT

Enochian Biosciences, Inc.

Century City Medical Plaza
Suite 906 2080 Century Park East
Los Angeles, CA 90067-2012
United States
786 888 1685
http://www.enochianbio.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees10

Key Executives

NameTitlePayExercisedYear Born
Dr. Mark R. Dybul M.D.Chief Exec. Officer & Director430kN/A1963
Ms. Luisa PucheChief Financial Officer280kN/A1964
Ms. Evelyn D'AnConsultant83kN/A1963
Dr. Serhat GümrükcüCo-Founder & InventorN/AN/AN/A
Dr. Wenshi WangSr. VP of OperationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, focuses on development of human therapeutics for infectious diseases and cancers. The company's lead candidate include ENOB-HV-01 for autologous HIV curative treatment. Its pipeline development products consist of ENOB-HV-11, a preventive HIV vaccine; and ENOB-HV-12, a therapeutic HIV vaccine. The company's pipeline development products also include ENOB-HB-01, a coopting Hepatitis B polymerase; ENOB-DC-01, an off-the-shelf DC vaccine pulsed with MCV lysate; ENOB-DC-11 innovative DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intratumoral injection. The company has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Center, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. Enochian Biosciences, Inc. is headquartered in Los Angeles, California.

Corporate Governance

Enochian Biosciences, Inc.’s ISS Governance QualityScore as of July 1, 2021 is 9. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 2; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.